

Medicate International Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
- Revenue Growth -13.60%
- Profit Growth -23.24%
- Ebitda -5.70%
- Net Worth 102.24%
- Total Assets 23.47%
About Medicate International
Medicate International Private Limited (MIPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 May 2015 (Nine years and 11 months 28 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.00 Cr.
Ashwini Tripathi and Laxmi serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74140DL2015PTC280215
- Company No.
280215
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Medicate International Private Limited offer?
Medicate International Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Injection, Antibiotic Tablets & Capsules, Cycloserine Capsule, Anti Cancer Medicines, Xbira Tablet, Melphalan Tablets, Alphalan Melphalan, Geftinat Tablet, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Medicate International?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ashwini Tripathi ![]() | Director | 14-May-2015 | Current |
Laxmi ![]() | Director | 14-May-2015 | Current |
Financial Performance of Medicate International.
Medicate International Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.6% decrease. The company also saw a substantial fall in profitability, with a 23.24% decrease in profit. The company's net worth Soared by an impressive increase of 102.24%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Medicate International?
Unlock access to Medicate International's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Related Corporates (Common Directorship)
- Briston Pharmaceutics Private Limited
Ashwini Tripathi is a mutual person
- W&B Health Care Private Limited
Ashwini Tripathi and Laxmi are mutual person
- Vikeshi Microcare Foundation
Ashwini Tripathi is a mutual person
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
05 Jun 2017 | Others | ₹1.00 Cr | Open |
How Many Employees Work at Medicate International?
Unlock and access historical data on people associated with Medicate International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Medicate International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicate International's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Medicate International
Recent activity within the organization
- Annual General Meeting
Medicate International Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Medicate International Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge with Others amounted to Rs. 10.00 M with Charge ID 100102566 was registered on 05 Jun 2017.
- Director Appointment
Ashwini Tripathi was appointed as a Director was appointed as a Director on 14 May 2015 & has been associated with this company since 9 years 11 months .
- Director Appointment
Laxmi was appointed as a Director was appointed as a Director on 14 May 2015 & has been associated with this company since 9 years 11 months .
- Company Incorporation
Medicate International Private Limited was registered on 14 May 2015 with Roc Delhi & aged 9 years 11 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Medicate International Private Limited?
Medicate International Private Limited was incorporated on 14 May 2015.
What is authorized share capital and paid-up capital of Medicate International Private Limited?
The authorized share capital of Medicate International Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Who are the current board members & directors of Medicate International Private Limited?
Currently 2 directors are associated with Medicate International Private Limited.
- Ashwini Tripathi
- Laxmi
What is the registered address of Medicate International Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Medicate International Private Limited is House No 3013/2-A Khasra 69 G Floor Gali No-19, Ranjit Nagar India, New Delhi, 110008.
What is the corporate identification number (CIN) and company number of Medicate International Private Limited?
The corporate identification number (CIN) of Medicate International Private Limited is U74140DL2015PTC280215 and the company number is 280215 as per Ministry of Corporate Affairs (MCA).
What is the official website of Medicate International Private Limited?
The Official website of Medicate International Private Limited is https://www.medicatepharma.com
What has been the recent revenue trend for Medicate International Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Medicate International Private Limited has fallen by -13.60%.
What change has been observed in the net worth of Medicate International Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Medicate International Private Limited has experienced an upsurge of 102.24%.
What are the total open charges for Medicate International Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Medicate International Private Limited amount to ₹ 1.00 Cr.
When was the last Balance Sheet of Medicate International Private Limited filed with the ROC?
The most recent Balance Sheet for Medicate International Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records